TABLE 2

In vivo models of drug-resistant seizures

For references, see text.

Seizure or epilepsy modelSpeciesMode of seizure or epilepsy inductionChronic modelDevelopment of spontaneous seizuresSelection of responders and nonresponders reportedThroughput
6-Hz seizure modelMouseTranscorneal electrical stimulationNoNon.a.High
6-Hz seizure modelRatTranscorneal electrical stimulationNoNon.a.High
Allylglycine-induced seizuresMouseIntraperitoneal administration of chemoconvulsantNoNon.a.High
Allylglycine-induced seizuresZebrafish larvaeBath application of chemoconvulsantNoNon.a.Very high
6-Hz kindlingMouseTranscorneal electrical stimulationYesNoNoIntermediate
Lamotrigine-resistant kindled animalsRatRepeated electrical stimulation of the amygdalaYesNoNoIntermediate
Lamotrigine-resistant kindled animalsMouseRepeated electrical stimulation of the amygdalaYesNoNoIntermediate
Intrahippocampal kainate modelMouseIntracerebral injection of kainateYesYesYesIntermediate
Post-traumatic seizuresRatFluid percussion injuryYesYesNoLow
Cortical dysplasia modelRatIn utero exposure to methylazoxymethanol acetate plus kainate exposureYesNoNoLow
Dravet modelsMiceGenetic modulationYesYesNoLow
NMDA model of epileptic spasmsRat (immature)Intraperitoneal administration of chemoconvulsantNoNoNoHigh
Multiple-hit model of infantile spasmsRatPN3 unilateral i.c.v. doxorubicin and intracortical lipopolysaccharide plus PN5 intraperitoneal p-chlorophenylalanine (→ increases spasm frequency)YesYesNoLow
Phenytoin-selected kindled animalsRatRepeated electrical stimulation of the amygdalaYesNoYesLow
Phenobarbital-selected animals with spontaneous seizuresRatProlonged electrical stimulation of amygdala induction of a status epilepticusYesYesYesLow
Canine patients with DREDogNatural disease (structural or idiopathic according to IVETF guidelines)YesYesYes (based on clinical response)Very low
  • i.c.v., intracerebroventricular; IVETF, International Veterinary Epilepsy Task Force; n.a., not applicable; PN, postnatal day.